Literature DB >> 20438764

Modulation of the CRH system by substance P/NKA in an animal model of depression.

Pamela Frisch1, András Bilkei-Gorzó, Ildiko Rácz, Andreas Zimmer.   

Abstract

It has been suggested by studies in animals and humans that substance P (SP) and its receptor neurokinin 1 (NK1R) play an important role in the pathology of depression. The pharmacological blockade or genetic deletion of the NK1 receptor, or the substance P coding gene tac1 led to a decreased emotionality and a reduction of depression-related behaviours in different animal models. In order to characterize molecular changes associated with reduced SP-NK1 signalling in animal models of depression, we assessed the regulation of the CRH system. First, tac1(-/-) animals and tac1(+/+) controls were subjected to bulbectomy, which induces physiological and behavioural changes that are relevant to depression. We demonstrate that tac1(-/-) animals, in contrast to tac1(+/+) controls, do not show anhedonia in the saccharine preference test after bulbectomy. Next, we studied expression levels of CRH, the receptors CRHR1 and CRHR2, and the binding protein CRHBP in the cortex and paraventricular nucleus using real-time RT-PCR. Our results show a strong induction of CRH, CRHBP and CRHR1 expression in the cortex of tac1(-/-), but not in tac1(+/+) animals. In the PVN, bulbectomized tac1(-/-) mice showed an elevated expression of CRHR1 and CRHR2. These results show that substance P/NKA is involved in modulating CRH signalling in an animal model of depression. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20438764     DOI: 10.1016/j.bbr.2010.04.044

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

Review 1.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

2.  Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.

Authors:  María Belén Poretti; Rahul S Sawant; Mathias Rask-Andersen; Marta Fiol de Cuneo; Helgi B Schiöth; Mariela F Perez; Valeria Paola Carlini
Journal:  Psychopharmacology (Berl)       Date:  2015-12-23       Impact factor: 4.530

3.  Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.

Authors:  Jing Wen; Yumin Xia; Ariel Stock; Jennifer S Michaelson; Linda C Burkly; Maria Gulinello; Chaim Putterman
Journal:  J Autoimmun       Date:  2013-04-08       Impact factor: 7.094

4.  Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats.

Authors:  Kouichi Yamamoto; Keiko Asano; Ayana Tasaka; Yuko Ogura; Seikou Kim; Yui Ito; Atsushi Yamatodani
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

5.  Modeling anorexia nervosa: transcriptional insights from human iPSC-derived neurons.

Authors:  P D Negraes; F R Cugola; R H Herai; C A Trujillo; A S Cristino; T Chailangkarn; A R Muotri; V Duvvuri
Journal:  Transl Psychiatry       Date:  2017-03-14       Impact factor: 6.222

Review 6.  Updated Review of the Toxicity of Selected Fusarium Toxins and Their Modified Forms.

Authors:  Adam Pierzgalski; Marcin Bryła; Joanna Kanabus; Marta Modrzewska; Grażyna Podolska
Journal:  Toxins (Basel)       Date:  2021-10-29       Impact factor: 4.546

7.  Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms.

Authors:  H Le-Niculescu; Y Balaraman; S D Patel; M Ayalew; J Gupta; R Kuczenski; A Shekhar; N Schork; M A Geyer; A B Niculescu
Journal:  Transl Psychiatry       Date:  2011-05-24       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.